Clearmind Medicine Shares Set to Reverse Split on Monday, October 5th (NASDAQ:CMND)

Clearmind Medicine Inc. (NASDAQ:CMND) shares are set to reverse split on the morning of Monday, October 5th. The 1-8 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 4th.

Clearmind Medicine Price Performance

Clearmind Medicine stock traded down $0.09 during midday trading on Thursday, hitting $0.72. The company’s stock had a trading volume of 219,393 shares, compared to its average volume of 1,131,579. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.31 and a quick ratio of 4.31. The stock’s 50-day moving average price is $1.41 and its 200-day moving average price is $3.93. Clearmind Medicine has a 12 month low of $0.71 and a 12 month high of $480.00.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings results on Thursday, September 10th. The company reported ($0.57) earnings per share for the quarter.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Clearmind Medicine from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 20th.

Clearmind Medicine Company Profile

Clearmind Medicine Inc is a biotechnology company focused on developing psychedelic-derived therapeutics for behavioral and mental health disorders. Its research programs are designed to address conditions with significant unmet medical needs, including alcohol use disorder and binge-related behaviors.

The company’s pipeline includes investigational compounds based on novel psychedelic molecules, including 5-methoxy-2-aminoindane (MEAI). Clearmind is studying these compounds for their potential to reduce harmful consumption patterns and support improved mental health outcomes.